Related Experiment Videos
Defective killer cell activity in patients with chronic active Epstein-Barr virus infection
H Wakiguchi1, M Fujieda, K Matsumoto
1Department of Pediatrics, Kochi Medical School, Japan.
Insights
Chronic active Epstein-Barr virus (EBV) infection is linked to reduced natural killer (NK) cell and EBV-specific cytotoxic T lymphocyte (EBV-CTL) activities, suggesting immune dysfunction in disease progression.
Area of Science:
- Immunology
- Virology
- Cellular Biology
Background:
- Chronic active Epstein-Barr virus (EBV) infection represents a persistent viral state.
- Immune surveillance, particularly cytotoxic cell activity, is crucial for controlling EBV.
- Dysregulation of immune responses may contribute to the chronicity of EBV infection.
Purpose of the Study:
- To investigate the functional status of natural killer (NK) cells, lymphokine-activated killer (LAK) cells, and Epstein-Barr virus-specific cytotoxic T lymphocytes (EBV-CTLs) in individuals with chronic active EBV infection.
- To determine if impaired killer cell activity contributes to the pathogenesis of chronic EBV infection.
Main Methods:
- Assessed NK cell activity against K-562 cell line.
- Measured spontaneous cytotoxicity against autologous EBV-transformed lymphoblastoid cell lines.
- Evaluated LAK activity against Raji cells.
- Determined EBV-CTL activity against autologous EBV-transformed lymphoblastoid cell lines.
- Utilized regression assays to assess EBV-CTL efficacy.
Main Results:
- Significantly lower NK cell activity was observed in patients compared to normal controls (p < 0.005).
- LAK activity against Raji cells was significantly reduced in patients (p < 0.02).
- EBV-CTL activity was significantly lower in patients than in seropositive controls (p < 0.005).
- Spontaneous cytotoxicity against autologous lymphoblastoid cells showed no significant difference between patients and controls.
- No regression of lymphoblastoid cells was observed with patient EBV-CTLs in regression assays.
Conclusions:
- Defects in both non-specific (NK, LAK) and specific (EBV-CTL) killer cell activities are implicated in the pathogenesis of chronic active EBV infection.
- Impaired immune control by cytotoxic cells may allow EBV to persist and establish a chronic active state.
- These findings highlight the importance of cellular immunity in controlling EBV and preventing chronic disease.
Abstract:
Natural killer (NK) cell activity, lymphokine activated killer (LAK) activity and Epstein-Barr virus specific cytotoxic T lymphocyte (EBV-CTL) activity were examined in 10 children with chronic active EB-virus infection and an adult with persistently positive early antigen-antibody to EB-virus. NK cell activity against erythroleukemia cell line K-562 was significantly (p less than 0.005) lower in the patients (22.3 +/- 8.5%, mean +/- SD) than in normal controls (40.4 +/- 15.9%). Spontaneous cytotoxicity against an EB-virus transformed autologous lymphoblastoid cell line was 15.0 +/- 7.6% in the patients, and was comparable to spontaneous cytotoxicity activity in normal controls (11.7 +/- 4.3%). LAK activity against Raji cells was significantly (p less than 0.02) lower in the patients (14.6 +/- 11.4%) than in normal controls (29.2 +/- 15.9%). EBV-CTL activity against an EB-virus transformed autologous lymphoblastoid cell line was significantly (p less than 0.005) lower in the patients (11.8 +/- 5.5%) than in seropositive normal controls (33.7 +/- 14.7%). No regression of the lymphoblastoid cell line was observed when EBV-CTL activity of the patients was tested by regression assay. It is conceivable that defects in both EB-virus specific and nonspecific killer cell activities play important roles in the pathogenetic abnormalities which allow EB-virus infection to progress to a chronic active state.